| Literature DB >> 18234071 |
Violaine Moreau1, Cécile Fleury, Dominique Piquer, Christophe Nguyen, Nicolas Novali, Sylvie Villard, Daniel Laune, Claude Granier, Franck Molina.
Abstract
BACKGROUND: Most methods available to predict protein epitopes are sequence based. There is a need for methods using 3D information for prediction of discontinuous epitopes and derived immunogenic peptides.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18234071 PMCID: PMC2262870 DOI: 10.1186/1471-2105-9-71
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1PEPOP. (A) Description of PEPOP. Step 1: The solvent accessible surface area is calculated from the 3D structure of a protein. Step 2: Segments of accessible and contiguous amino acids are listed, and the shortest Euclidian distance matrix between segments is calculated. Step 3: The segments are clustered according to the matrix (clusters can be displayed on the 3D structure of the Ag). Step 4: Peptides are designed according to the clustering analyses. (B) The PEPOP interface. Segments and clusters can interactively be displayed on a 3D view of the Ag.
Distribution of the residues of the HEL epitopes in the clusters identified by PEPOP
| PEPOP cluster | PEPOP segment | Position ([PDB: | mAb1 | |||||
| D1.3 | D11.15 | D44.1 | HyHEL-5 | HyHEL-10 | HyHEL-63 | |||
| Cluster1 | Segment17 | 93–94 | ||||||
| Segment18 | 96–97 | |||||||
| Segment19 | 100–103 | |||||||
| Cluster2 | Segment2 | 10–16 | ||||||
| Segment20 | 106–109 | |||||||
| Segment21 | 111–114 | |||||||
| Segment22 | 116–119 | |||||||
| Segment23 | 121–129 | |||||||
| Segment3 | 18–24 | |||||||
| Segment4 | 27–28 | |||||||
| Cluster3 | Segment10 | 56–57 | ||||||
| Segment11 | 59 | |||||||
| Segment12 | 61–63 | |||||||
| Segment13 | 65–68 | |||||||
| Segment14 | 70–79 | |||||||
| Segment15 | 81–82 | |||||||
| Segment16 | 84–90 | |||||||
| Segment8 | 41–49 | |||||||
| Segment9 | 53 | |||||||
| Cluster4 | Segment1 | 1–8 | ||||||
| Segment5 | 33–35 | |||||||
| Segment6 | 37 | |||||||
| Segment7 | 39 | |||||||
| amino acids not accessible | ||||||||
1 Ratio of the number of amino acids in the epitope included in the cluster to the total number of amino acids in the epitope. The epitopes were defined as in the original publication (D1.3 [54], D11.15 [55], D44.1 [56], HyHEL-5 [57], HyHEL-10 [58], HyHEL-63 [59]). Positions of the amino acids in the epitope included in the cluster are indicated in parentheses. The ratios are in bold for the major clusters.
Evaluation and comparison of the performances of PEPOP
| Ab – Ag complex1 | PDB | Epitope (number of amino acids) | PEPOP | CEP | DiscoTope | ||||||||
| Number of clusters containing epitopic residues/total number of clusters | Number of predicted residues of the epitope | Sp | Se | PPV | Sp | Se | PPV | Sp | Se | PPV | |||
| D1.3 – hen egg lysozyme [54] | 10 | 1/4 | 10 | 0.77 | 1.00 | 0.27 | 0.76 | 1.00 | 0.26 | 0.80 | 0.40 | 0.14 | |
| D44.1 – hen egg lysozyme [56] | 11 | 1/5 | 11 | 0.81 | 1.00 | 0.33 | 0.78 | 0.91 | 0.28 | 0.86 | 0.55 | 0.27 | |
| HyHEL-5 – hen egg lysozyme [57] | 14 | 1/5 | 13 | 0.83 | 0.93 | 0.41 | 0.88 | 0.00 | 0.00 | 0.78 | 0.00 | 0.00 | |
| Jel42 – HPr [60] | 16 | 2/8 | 13 | 0.93 | 0.81 | 0.72 | 0.90 | 0.75 | 0.63 | 0.97 | 0.06 | 0.33 | |
| D11.15 – hen egg lysozyme [55] | 10 | 2/5 | 8 | 0.95 | 0.80 | 0.57 | 0.90 | 0.10 | 0.08 | 0.82 | 0.30 | 0.13 | |
| 5G9 – tissue factor [61] | 18 | 1/3 | 14 | 0.75 | 0.78 | 0.25 | 0.84 | 0.28 | 0.15 | 0.84 | 0.17 | 0.10 | |
| BH151 – hemagglutinin [62] | 19 | 3/7 | 12 | 0.83 | 0.63 | 0.19 | 0.97 | 0.32 | 0.40 | 0.75 | 0.11 | 0.03 | |
| Bo2C11 – FVIII C2 domain [63] | 15 | 3/5 | 8 | 0.92 | 0.53 | 0.42 | 0.94 | 0.47 | 0.44 | 0.83 | 0.53 | 0.25 | |
| NC41 – neuraminidase [64] | 22 | 3/4 | 11 | 0.90 | 0.50 | 0.23 | 0.99 | 0.59 | 0.81 | 0.85 | 0.64 | 0.20 | |
| F9.13.7 – guinea fowl lysozyme [65] | 10 | 3/5 | 5 | 0.98 | 0.50 | 0.71 | 0.92 | 0.50 | 0.33 | 0.83 | 0.40 | 0.17 | |
| HyHEL-10 – hen egg lysozyme [58] | 16 | 3/5 | 8 | 0.99 | 0.50 | 0.89 | 0.96 | 0.56 | 0.64 | 0.87 | 0.44 | 0.32 | |
| HyHEL-63 – hen egg lysozyme [59] | 23 | 3/4 | 9 | 0.82 | 0.39 | 0.32 | 0.73 | 0.30 | 0.19 | 0.87 | 0.39 | 0.39 | |
| N10 – staphylococcal nuclease [66] | 18 | 3/6 | 6 | 0.87 | 0.33 | 0.29 | 0.88 | 0.06 | 0.07 | 0.66 | 0.33 | 0.13 | |
1 The corresponding reference is given in parentheses
nd: not determined (no results returned from the server)
Sp: specificity; Se: sensibility; PPV: positive predictive value (see Materials and methods)
Figure 2Comparison of known epitopes with the predicted major cluster. Amino acids in the epitope and in the major cluster are in green; those outside of the major cluster are in red; those non-accessible are in yellow; amino acids in the major cluster but not in the epitope are in blue. (A) Epitope on HEL recognized by mAb D44.1 (B) Epitope on HPr recognized by mAb Jel42.
Figure 3Example of peptides designed from the 3D structure of IA-2. The two peptides, #5 (A) and #6 (B) of Table 3, were constructed from the longest segment (segment 1: reference segment) to which were added the nearest neighbor segments (segment 2 to respectively segment 4 and segment 5), according to two different methods (respectively method NN and NNd). Segments indicated in the IA-2 sequence are in the same color as in the 3D structure.
Reactivity with the cognate Ag of the Abs obtained by immunization with the peptides
| Method2 | ||||||
| Ag | Peptide # | Peptide sequence1 | Reference segment3 | Method of extension4 | Area of extension5 | A450 nm for serum diluted 1:10 0006 |
| IA-2 | 1 | VSSQFSDAAQASPS | B | 1.75 | ||
| 2 | SPSSHSSTPSWCEEP | B | 0.30 | |||
| 3 | RYWPDEGASLYHVYEV | B | 0.36 | |||
| 4 | ALTAVAEEVNAILKALPQ | L | FPS | - | 3.62 | |
| 5 | NAILKALPQVKEIDLTAE | L | NN | CC | 0.14 | |
| 6 | qplaklianeatledksr | L | NNd | CC | 0.02 | |
| 7 | diekvgkaGPGNAILKALPQ | L | MD | CC | 0.02 | |
| 8 | ARIKLKVESSPSRSDYIN | T | FPS | SC | 1.83 | |
| TPO | 9 | VVTDDDRYSDLLMAWGQ | B | 3.76 | ||
| 10 | ARLRDSGRAYLPFVPP | B | 0.46 | |||
| 11 | PYEGYDSTANPTVSNVF | B | 0.06 | |||
| 12 | EDFESCDSIPGMNLEA | B | 0.39 | |||
| 13 | RRLDASFQEHPDLPGLWLH | L | FPS | - | 3.75 | |
| 14 | ASFQEHPDLPGRLWQFVLS | L | NN | CC | 0.33 | |
| 15 | APEPGIPGERPCPPRAPAA | T | NN | TC | 0.47 | |
| 16 | ASFQEHPDLPGRAPEPGIPGE | L | MD | CC | 0.14 | |
| IL8 | 17 | PKFIKELRVIESGPHCANT | L | FPS | - | 0.16 |
| 18 | ENWVQRVVEKFLKRAENS | T | FPS | SC | 2.25 | |
1 Amino acids in lower case are D-amino acids. 2 Algorithm used to predict the sequence of the immunogenic peptide: B for BEPITOPE otherwise PEPOP. 3 The reference segment chosen is the longest (L: longest) or the segment at the top (T) of the list of all the segments ranked according to the five characteristics indicated in the text. 4 The method of extension chosen is either elongation with the flanking protein sequence (FPS); addition of the nearest neighbor (NN) segment(s) regardless of the sense of the segment added: if the segment is in the unnatural sense, i.e., from the C-terminus to the N-terminus, it is synthesized using D-amino acids (NNd); or manual design (MD). 5 The area of extension is the cluster top of the list (TC: top cluster) of the clusters ranked according to the five characteristics (see the text), or the cluster containing the selected reference segment (CC: containing cluster), or a user selected cluster (SC: selected cluster), or none when the reference segment is the longest and the method is the FPS. 6 Positive reactivities in the indirect ELISA are values over 0.2, and strong reactivities are values over 1.0. Control experiments done by using the preimmune serum gave values ranging from 0.0020 to 0.0028. The given values correspond to specific absorbances (A450 nm immune serum – A450 nm preimmune serum).
Figure 4Sandwich immunoassay design for IA-2. (A) 3D view. Peptide #1 (in red) and peptide #4 (in blue) are represented on the 3D structure of IA-2. (B) Graphic representation. The graph indicates the reactivity of the polyclonal (Abs) with IA-2, in a sandwich-type ELISA format. The Ag, captured by the immobilized Ab, is detected by a biotinylated Ab, followed by addition of streptavidin-peroxidase. Reactivity of×, anti-peptide #4 with IA-2, detected by anti-peptide #1; ▲, anti-peptide #4 with TPO, detected by anti-peptide #1; ■, anti-peptide #15 with IA-2, detected by anti-peptide #1; ◆, anti-peptide #15 with TPO, detected by anti-peptide #1.